看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 5.1x - 5.6x | 5.3x |
| Historical Pb Multiple | 5.0x - 7.6x | 7.1x |
| Fair Value | ﷼89.76 - ﷼99.20 | ﷼94.48 |
| Upside | 19.8% - 32.4% | 26.1% |
| Benchmarks | - | Full Ticker |
| Al Hammadi Holding Company | 400,700.0% | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 401,300.0% | SASE:4013 |
| Middle East Healthcare Company | 400,900.0% | SASE:4009 |
| National Medical Care Company | 400,500.0% | SASE:4005 |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 401,700.0% | SASE:4017 |
| Mouwasat Medical Services Company | 400,200.0% | SASE:4002 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4007 | 4013 | 4009 | 4005 | 4017 | 4002 | |||
| SASE:4007 | SASE:4013 | SASE:4009 | SASE:4005 | SASE:4017 | SASE:4002 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 29.5% | 21.6% | 23.6% | 30.1% | -0.9% | 8.9% | ||
| 3Y CAGR | 50.8% | 18.9% | 154.0% | 29.8% | -4.9% | 3.8% | ||
| Latest Twelve Months | -9.1% | 8.3% | 1089.3% | 8.7% | 17.5% | 6.1% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 21.0% | 20.1% | 4.3% | 18.5% | 11.5% | 26.4% | ||
| Prior Fiscal Year | 25.8% | 21.5% | 0.6% | 22.3% | 12.0% | 24.3% | ||
| Latest Fiscal Year | 29.4% | 20.7% | 9.8% | 23.0% | 10.3% | 22.4% | ||
| Latest Twelve Months | 24.1% | 18.6% | 13.3% | 21.1% | 10.8% | 23.3% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 12.3% | 29.4% | 7.0% | 14.9% | 15.2% | 22.5% | ||
| Prior Fiscal Year | 17.1% | 33.1% | 1.3% | 17.7% | 19.2% | 21.2% | ||
| Latest Twelve Months | 15.0% | 33.0% | 23.2% | 19.5% | 11.0% | 20.7% | ||
| Next Fiscal Year | 16.6% | 33.5% | 19.3% | 19.5% | 10.2% | 22.9% | ||
| Two Fiscal Years Forward | 15.7% | 36.1% | 16.1% | 19.0% | 10.6% | 19.6% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 4.5x | 7.1x | 1.8x | 5.3x | 3.0x | 4.9x | ||
| Price / LTM EPS | 18.6x | 38.0x | 13.5x | 25.1x | 28.1x | 21.1x | ||
| Price / Book | 2.7x | 12.0x | 3.0x | 4.6x | 3.0x | 4.2x | ||
| Price / Fwd Book | 2.6x | 11.0x | 2.7x | 4.3x | 2.8x | 3.7x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 2.7x | 3.0x | 12.0x | |||||
| Historical P/B Ratio | 5.0x | 7.1x | 7.6x | |||||
| Selected P/B Multiple | 5.1x | 5.3x | 5.6x | |||||
| (x) Book Value | 3,552 | 3,552 | 3,552 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4007 | 4013 | 4009 | 4005 | 4017 | 4002 | |
| Value of Common Equity | 5,430 | 89,040 | 5,357 | 7,888 | 9,044 | 14,990 | |
| (/) Shares Outstanding | 160.0 | 350.0 | 92.0 | 44.7 | 230.0 | 200.0 | |
| Implied Stock Price | 33.94 | 254.40 | 58.20 | 176.50 | 39.32 | 74.95 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 33.94 | 254.40 | 58.20 | 176.50 | 39.32 | 74.95 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |